M. Juweid and B. Cheson, Role of Positron Emission Tomography in Lymphoma, Journal of Clinical Oncology, vol.23, issue.21, 2005.
DOI : 10.1200/JCO.2005.01.904

J. Czernin, W. Weber, and H. Herschman, Molecular Imaging in the Development of Cancer Therapeutics, Annual Review of Medicine, vol.57, issue.1, pp.99-118, 2006.
DOI : 10.1146/annurev.med.57.080904.190431

T. Manabe and H. Imura, Over-expression of facilitative glucose transporter genes in 16 human cancer, Biochem Biophys Res Commun, vol.170, pp.223-253, 1990.

T. Ido, C. Wan, and J. Casella, Labeled 2-deoxy-D-glucose analogs, pp.18-18, 1978.

O. Sakurada and M. Shinohara, The [14C]deoxyglucose method for the 22 measurement of local cerebral glucose utilization: theory, procedure, and normal 23 values in the conscious and anesthetized albino rat, J Neurochem, vol.28, issue.8, pp.897-916, 1977.

C. Burton, P. Ell, and D. Linch, The role of PET imaging in lymphoma, British Journal of Haematology, vol.9, issue.6, 2004.
DOI : 10.1023/A:1008327127033

S. Cherry, In vivo positron-emission tomography imaging of progression and 28 transformation in a mouse model of mammary neoplasia, Proc Natl Acad Sci U S A, vol.29, issue.30, pp.11438-11481, 2004.

S. Lyons, Advances in imaging mouse tumour models in vivo, J Pathol, vol.31, issue.32, pp.194-205, 2005.

J. Briones, J. Timmerman, and R. Levy, In vivo antitumor effect of CD40L- 33 transduced tumor cells as a vaccine for B-cell lymphoma, Cancer Res, vol.62, pp.3195-3204, 2002.